Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Research shows that even people with perfect adherence to diet and exercise regain significant weight within a year of discontinuation, confirming that biology, not behavior, drives rebound
Key arguments highlight that: Tirzepatide can lead to a body mass reduction of approximately 20-25%, significantly surpassing the 14.9% average loss associated with Semaglutide
Headache or fatigue Mild headache or tiredness has been reported by some patients, typically easing as the body adjusts
Dulaglutid (Trulicity): Haftalk enjeksiyon olarak kullanlan bir dier GLP-1 agonistidir ve tip 2 diyabet tedavisinde yaygn olarak kullanlr
Additionally, tirzepatide may cause fewer gastrointestinal side effects and provides extra benefits for patients with type 2 diabetes or increased cardiovascular risk, including improved glucose control and reduced cardiovascular event risk
